Physician profile
Daniel J Higgins
NPI 1588607717
$1,521.20
in general payments reported to CMS, 2019-2025
33 companies · $504 in 2025
The $504 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $28.36 · 2022: $156 · 2023: $116 · 2024: $118 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $658 · Education: $80.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $658.04 |
| Education | $80.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $195.58 | 2019 | |
| Endo Pharmaceuticals INC. | $131.28 | 2019-2020 | |
| Janssen Biotech, INC. | $120.09 | 2023-2025 | Erleada, Akeega |
| Abbvie INC. | $109.20 | 2019-2025 | |
| Medtronic, INC. | $76.96 | 2023-2024 | Interstim |
| Valencia Technologies Corporation | $76.90 | 2025 | Ecoin Device Kit |
| Histosonics, INC. | $73.29 | 2025 | |
| Ferring Pharmaceuticals INC. | $68.12 | 2019-2024 | Adstiladrin |
| Pfizer INC. | $61.63 | 2019-2025 | |
| Olympus America INC. | $52.16 | 2025 | Itind System |
| Dendreon Pharmaceuticals LLC | $51.15 | 2019 | |
| Boston Scientific Corporation | $51.05 | 2025 | Polaris Ultra, Lithovue |
| Merck Sharp & Dohme LLC | $37.50 | 2025 | Keytruda, Lynparza |
| Coloplast Corp | $35.51 | 2022 | |
| Covidien LP | $33.10 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $31.87 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $26.24 | 2025 | Orgovyx |
| Neotract INC. | $24.77 | 2019 | |
| Ethicon US, LLC | $24.72 | 2024 | Vistaseal, Surgiflo Hemostatic Matrix, Surgicel Nu-Knit |
| Palette Life Sciences, INC. | $24.21 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.77 | 2025 | |
| Amgen INC. | $19.29 | 2022 | |
| Teleflex LLC | $18.46 | 2022 | |
| Sun Pharmaceutical Industries INC. | $18.15 | 2024 | |
| 180 Medical, INC. | $17.85 | 2019 | |
| Intuitive Surgical, INC. | $17.40 | 2019 | |
| Immunitybio, INC. | $17.04 | 2025 | |
| Tolmar, INC. | $17.02 | 2023 | |
| Smith+Nephew, INC. | $16.80 | 2022 | |
| Astellas Pharma US INC | $16.56 | 2025 | Xtandi |
| Blue Earth Diagnostics | $14.22 | 2019 | |
| Travere Therapeutics, INC. | $11.99 | 2019 | |
| Medtronic USA, INC. | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.